Cesium-induced QT-interval prolongation in an adolescent

Pharmacotherapy

Volumn 28, Issue 8, 2008, Pages 1059-1065

  O'Brien, Catherine E ^a   Harik, Nada ^b,c   James, Laura P ^b,c   Seib, Paul M ^a,c   Stowe, Cindy D ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c ARKANSAS CHILDREN S HOSPITAL   (United States)

Author keywords

Adverse drug reactions; Arrhythmias; Cesium chloride; Complementary and alternative medicine; QT interval prolongation

Indexed keywords

ALOE VERA EXTRACT; CALCIUM; CESIUM CHLORIDE; CISPLATIN; DIMETHYL SULFOXIDE; DOXORUBICIN; LIDOCAINE; MULTIVITAMIN; POTASSIUM CHANNEL; UBIDECARENONE; VITAMIN D;

ADOLESCENT; ALTERNATIVE MEDICINE; ARTICLE; CASE REPORT; CONTINUOUS INFUSION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; EMERGENCY WARD; FEMALE; HEART ARRHYTHMIA; HEART REPOLARIZATION; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INTENSIVE CARE UNIT; LIVER CELL CARCINOMA; METASTASIS; MULTIPLE CYCLE TREATMENT; NARANJO ADVERSE DRUG REACTION PROBABLITY SCALE; QT INTERVAL; QT PROLONGATION; R WAVE; RATING SCALE; RISK BENEFIT ANALYSIS; SELF REPORT; SYNCOPE; T WAVE; TERMINAL DISEASE; TORSADE DES POINTES; TUMOR REGRESSION;

ADOLESCENT; CARCINOMA, HEPATOCELLULAR; CESIUM; CHLORIDES; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LIVER NEOPLASMS;

EID: 48249099286     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.28.8.1059     Document Type: Article

References (38)

1. Howenstine J. Use of cesium chloride to cure malignancies. Available from http://www.newswithviews.com/Howenstine/james14.htm. Accessed June 18, 2007.
2. Barefoot R. Cure America! Available from www.barefootscureamerica. com. Accessed May 14, 2007.
3. Brewer Science Library. High pH cancer therapy with cesium. Available from http://www.mwt.net/~drbrewer/brew_art.htm. Accessed June 18, 2007.
4. Buche J. Cesium chloride (high pH therapy): A cure for cancer? Available from http://www.healingcancernaturally.com/cesiumchloride-high-ph- therapy.html. Accessed June 18, 2007.
5. Bailie DS, Inoue H, Kaseda S, Ben-David J, Zipes DP. Magnesium suppression of early afterdepolarizations and ventricular tachyarrhythmias induced by cesium in dogs. Circulation 1988;77:1395-402.
6. Patterson E, Szabo B, Scherlag BJ, Lazzara R. Early and delayed afterdepolarizations associated with cesium chloride-induced arrhythmias in the dog. J Cardiovasc Pharmacol 1990;15:323-31.
7. Weissenburger J, Davy JM, Chezalviel F. Experimental models of torsades de pointes. Fundam Clin Pharmacol 1993;7:29-38.
8. Satoh T, Zipes DP. Cesium-induced atrial tachycardia degenerating into atrial fibrillation in dogs: atrial torsades de pointes? J Cardiovasc Electrophysiol 1998;9:970-5.
9. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
10. Saliba W, Erdogan O, Niebauer M. Polymorphic ventricular tachycardia in a woman taking cesium chloride. Pacing Clin Electrophysiol 2001;24:515-17.
11. Pinter A, Dorian P, Newman D. Cesium-induced torsades de pointes. N Engl J Med 2002;346:383-4.
12. Lyon AW, Mayhew WJ. Cesium toxicity: a case of self-treatment by alternate therapy gone awry. Ther Drug Monit 2003;25:114-16.
13. Dalal AK, Harding JD, Verdino RJ. Acquired long QT syndrome and monomorphic ventricular tachycardia after alternative treatment with cesium chloride for brain cancer. Mayo Clin Proc 2004;79:1065-9.
14. Curry TB, Gaver R, White RD. Acquired long QT syndrome and elective anesthesia in children. Paediatr Anaesth 2006;16:471-8.
15. Vyas H, Johnson K, Houlihan R, Bauer BA, Ackerman MJ. Acquired long QT syndrome secondary to cesium chloride supplement. J Altern Complement Med 2006;12:1011-14.
16. Fish FA, Prakash C, Roden DM. Suppression of repolarization- related arrhythmias in vitro and in vivo by low-dose potassium channel activators. Circulation 1990;82:1362-9.
17. Isenberg G. Cardiac purkinje fibers: cesium as a tool to block inward rectifying potassium currents. Pflugers Arch 1976;365:99-106.
18. Levine JH, Spear JF, Guarnieri T, et al. Cesium chloride-induced long QT syndrome: demonstration of afterdepolarizations and triggered activity in vivo. Circulation 1985;72:1092-103.
19. Nayebpour M, Nattel S. Pharmacologic response of cesium-induced ventricular tachyarrhythmias in anesthetized dogs. J Cardiovasc Pharmacol 1990;15:552-61.
20. Senges JC, Sterns LD, Freigang KD, et al. Cesium chloride induced ventricular arrhythmias in dogs: three-dimensional activation patterns and their relation to the cesium dose applied. Basic Res Cardiol 2000;95:152-62.
21. Hanich RF, Levine JH, Spear JF, Moore EN. Autonomic modulation of ventricular arrhythmia in cesium chloride-induced long QT syndrome. Circulation 1988;77:1149-61.
22. Drici MD, Clement N. Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome. Drug Saf 2001;24:575-85.
23. Al-Khatib SM, LaPointe NM, Kramer JM, Califf RM. What clinicians should know about the QT interval. JAMA 2003;289:2120-7.
24. Benoit SR, Mendelsohn AB, Nourjah P, Staffa JA, Graham DJ. Risk factors for prolonged QTc among US adults: third national health and nutrition examination survey. Eur J Cardiovasc Prev Rehabil 2005;12:363-8.
25. Gupta A, Lawrence AT, Krishnan K, Kavinsky CJ, Trohman RG. Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes. Am Heart J 2007;153:891-9.
26. Elliott P. Pathogenesis of cardiotoxicity induced by anthracyclines. Semin Oncol 2006;33:S2-7.
27. Milberg P, Fleischer D, Stypmann J, et al. Reduced repolarization reserve due to anthracycline therapy facilitates torsade de pointes induced by I(kr) blockers. Basic Res Cardiol 2007;102:42-51.
28. Owczuk R, Wujtewicz MA, Sawicka W, Wujtewicz M, Swierblewski M. Is prolongation of the QTc interval during isoflurane anaesthesia more prominent in women pretreated with anthracyclines for breast cancer? Br J Anaesth 2004;92: 658-61.
29. Arbel Y, Swartzon M, Justo D. QT prolongation and torsades de pointes in patients previously treated with anthracyclines. Anticancer Drugs 2007;18:493-8.
30. Rundo J. The metabolism of biologically important radionuclides. VI. A survey of the metabolism of caesium in man. Br J Radiol 1964;37:108-14.
31. Braverman ER, Sohler A, Pfeiffer CC. Cesium chloride: preventive medicine for radioactive cesium exposure? Med Hypoth 1988;26:93-5.
32. Williams M, Wohlers DW, Citra M, Diamond GL, Swarts SG. Toxicological profile for cesium. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry, 2004.
33. Guns ES, Xie X, Fedoruk M, et al. pH modulation using CsCl enhances therapeutic effects of vitamin D in LNCaP tumor bearing mice. Prostate 2005;64:316-22.
34. Brewer AK. The high pH therapy for cancer tests on mice and humans. Pharmacol Biochem Behav 1984;21(suppl 1):1-5.
35. Sartori HE. Cesium therapy in cancer patients. Pharmacol Biochem Behav 1984;21(suppl 1):11-13.
36. Federal Trade Commission. North American health claim surf day targets internet ads. Available from www.ftc.gov/opa/1997/11/hlthsurf.shtm. Accessed May 14, 2007.
37. Federal Trade Commission. "Operation cure-all" targets internet health fraud. Available from www.ftc.gov/opa/1999/06/opcureall.shtm. Accessed May 14, 2007.
38. Federal Trade Commission. FTC and FDA coordinate for new consumer health information initiative. Available from www.ftc.gov/opa/2002/12/ftcfda. shtm. Accessed May 14, 2007.